In-house tooth-supported guide for the injection of botulinum toxin into the lateral pterygoid muscle using Blue Sky Plan software: A technical note

Author(s):  
T. Casatuto ◽  
M. Gosselin ◽  
B. Lehre ◽  
C. Vandersteen ◽  
E. Ehrmann ◽  
...  
Author(s):  
P. Martos-Diaz ◽  
FJ. Rodriguez-Campo ◽  
R. Bances-del Castillo ◽  
O. Altura-Guillen ◽  
GY. Cho-Lee ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Aleli Tôrres Oliveira ◽  
Anderson Aparecido Camilo ◽  
Paulo Roberto Valle Bahia ◽  
Antonio Carlos Pires Carvalho ◽  
Marcos Fabio DosSantos ◽  
...  

Background.The uncoordinated activity of the superior and inferior parts of the lateral pterygoid muscle (LPM) has been suggested to be one of the causes of temporomandibular joint (TMJ) disc displacement. A therapy for this muscle disorder is the injection of botulinum toxin (BTX), of the LPM. However, there is a potential risk of side effects with the injection guide methods currently available. In addition, they do not permit appropriate differentiation between the two bellies of the muscle. Herein, a novel method is presented to provide intraoral access to the superior head of the human LPM with maximal control and minimal hazards.Methods.Computational tomography along with digital imaging software programs and rapid prototyping techniques were used to create a rapid prototyped guide to orient BTX injections in the superior LPM.Results.The method proved to be feasible and reliable. Furthermore, when tested in one volunteer it allowed precise access to the upper head of LPM, without producing side effects.Conclusions.The prototyped guide presented in this paper is a novel tool that provides intraoral access to the superior head of the LPM. Further studies will be necessary to test the efficacy and validate this method in a larger cohort of subjects.


2021 ◽  
Vol 14 (4) ◽  
pp. e238766
Author(s):  
Abdullah Kanbour ◽  
Michael James Leslie Hurrell ◽  
Peter Ricciardo

Complications related to lateral pterygoid muscle (LPM) botulinum toxin A (BtA) injection for recurrent temporomandibular joint dislocation are uncommon. No cases of velopharyngeal dysfunction (VPD) following LPM BtA injection have been reported to date. This report details the perioperative and follow-up findings for a patient developing VPD following LPM BtA injection.


Sign in / Sign up

Export Citation Format

Share Document